VITALANT: Form 990, tax year 2015

View the entire original 990 at ProPublica ↗

Organization
VITALANT (EIN 86-0098929)
Tax period
2015-01-01 to 2015-12-31
Filed
2016-11-14
IRS object ID
201613199349312216
Schema version
2015v2.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2016-11-14T19:53:50-06:00ReturnTs
Tax Period End2015-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1ERNST & YOUNG US LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1TWO NORTH CENTRAL AVENUE STE 2300AddressLine1Txt
CityPHOENIXCityNm
State AbbreviationAZStateAbbreviationCd
ZIP85004ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2015-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN860098929EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1BLOOD SYSTEMS INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% SUSAN BARNESInCareOfNm
Business Name ControlBLOOBusinessNameControlTxt
Phone4809464201PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1PO BOX 1867AddressLine1Txt
CitySCOTTSDALECityNm
State AbbreviationAZStateAbbreviationCd
ZIP85252ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonSUSAN L BARNESPersonNm
Person TitleEXECUTIVE VP & CFOPersonTitleTxt
Phone4809464201PhoneNum
Signature2016-11-14SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonBRENDA GRIESEMERPreparerPersonNm
PTINP00264669PTIN
Phone6023223000PhoneNum
FieldValueIRS element (for citing)
Tax2015TaxYr
Build TS2017-02-10 21:41:12ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerJ DANIEL CONNORPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1SAME AS C ABOVEAddressLine1Txt
CitySCOTTSDALECityNm
State AbbreviationAZStateAbbreviationCd
ZIP85252ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$772,736,486GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Group Exemption6167GroupExemptionNum
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.bloodsystems.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1943FormationYr
Legal Domicile StateAZLegalDomicileStateCd
Activity Or MissionBLOOD BANKING, PLASMA DERIVATIVE DISTRIBUTION, AND RESEARCHActivityOrMissionDesc
Voting Members Governing Body19VotingMembersGoverningBodyCnt
Voting Members Independent19VotingMembersIndependentCnt
Total Employee2877TotalEmployeeCnt
Total Volunteers1100TotalVolunteersCnt
Total Gross UBI$171,758,981TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$785,626NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$8,365,565PYContributionsGrantsAmt
CY Contributions Grants$7,622,066CYContributionsGrantsAmt
PY Program Service Revenue$488,666,748PYProgramServiceRevenueAmt
CY Program Service Revenue$578,648,022CYProgramServiceRevenueAmt
PY Investment Income$5,190,677PYInvestmentIncomeAmt
CY Investment Income$48,639,119CYInvestmentIncomeAmt
PY Other Revenue-$128,815PYOtherRevenueAmt
CY Other Revenue$4,991,255CYOtherRevenueAmt
PY Total Revenue$502,094,175PYTotalRevenueAmt
CY Total Revenue$639,900,462CYTotalRevenueAmt
PY Grants And Similar Paid$235,610PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$226,593CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$176,835,161PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$171,596,686CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$350,819,704PYOtherExpensesAmt
CY Other Expenses$437,305,133CYOtherExpensesAmt
PY Total Expenses$527,890,475PYTotalExpensesAmt
CY Total Expenses$609,128,412CYTotalExpensesAmt
PY Revenues Less Expenses-$25,796,300PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$30,772,050CYRevenuesLessExpensesAmt
Total Assets BOY$401,630,955TotalAssetsBOYAmt
Total Assets EOY$382,520,351TotalAssetsEOYAmt
Total Liabilities BOY$200,115,938TotalLiabilitiesBOYAmt
Total Liabilities EOY$192,026,029TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$201,515,017NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$190,494,322NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionSEE SCHEDULE OMissionDesc
Significant New Program SrvcYes (true)SignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$259,056,955ExpenseAmt
Grant$226,593GrantAmt
Revenue$255,156,634RevenueAmt
DescUNITED BLOOD SERVICES BLOOD BANKING - SEE SCHEDULE ODesc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$293,562,436ExpenseAmt
Grant$0GrantAmt
Revenue$304,884,979RevenueAmt
DescBIOCARE BIOLOGICALS - SEE SCHEDULE ODesc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$16,112,696ExpenseAmt
Grant$0GrantAmt
Revenue$15,625,732RevenueAmt
DescBLOOD SYSTEMS RESEARCH INSTITUTE - SEE SCHEDULE ODesc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$12,150,300TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$0TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$8,067,289TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$580,882,387TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesfalseLobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Temp Or Permanent EndowmentsYes (true)TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtfalseIndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgfalseMoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsYes (true)TaxExemptBondsInd
Invest Tax Exempt BondsfalseInvestTaxExemptBondsInd
Escrow AccountfalseEscrowAccountInd
On Behalf Of IssuerfalseOnBehalfOfIssuerInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingYes (true)LoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemYes (true)BusinessRlnWithFamMemInd
Business Rln With Officer EntfalseBusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityYes (true)RelatedEntityInd
Related Organization Ctrl EntYes (true)RelatedOrganizationCtrlEntInd
Transaction With Control EntYes (true)TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document462IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee2877EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (true)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (true)Form990TFiledInd
Foreign Financial AccountYes (true)ForeignFinancialAccountInd
Foreign CountryCJForeignCountryCd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members19GoverningBodyVotingMembersCnt
Independent Voting Member19IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersYes (true)LocalChaptersInd
Policies Reference ChaptersYes (true)PoliciesReferenceChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VentureYes (true)InvestmentInJointVentureInd
Written Policy Or ProcedureYes (true)WrittenPolicyOrProcedureInd
States Where Copy Of Return Is FldAZStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonSUSAN BARNESPersonNm
Phone4806755696PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line16210 E OAK STREETAddressLine1Txt
CitySCOTTSDALECityNm
State AbbreviationAZStateAbbreviationCd
ZIP85257ZIPCd
FieldValueIRS element (for citing)
Info In Schedule O Part VIIYes (X)InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (48 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerIndKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeIndFormer Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
HEATHER ALLEN MD
TRUSTEE3.00.0Yes (X)$26,000$0$0
James R Allen MD
Trustee3.00.0Yes (X)$24,000$0$0
Linda Blessing PhD
Trustee3.01.0Yes (X)$30,250$0$0
William A Dittman MD
Trustee2.01.0Yes (X)$21,000$0$0
Armando B Flores
Trustee5.01.0Yes (X)$23,500$0$0
Bill Gates
Trustee2.00.0Yes (X)$17,000$0$0
William G Green
Trustee2.00.0Yes (X)$26,500$0$0
Michael C Jensen
Trustee2.00.0Yes (X)$21,000$0$0
F Leonard Johnson MD
Trustee2.00.0Yes (X)$18,000$0$0
John Lewis
Trustee/Chair3.01.0Yes (X)$50,750$0$0Yes (X)
Pierre Noel MD
Trustee2.00.0Yes (X)$23,000$0$0
James Peterson
Trustee (AS OF 4/15)2.00.0Yes (X)$16,000$0$0
Kathleen S Pushor
Trustee3.00.0Yes (X)$23,250$0$0
Antonio Ruiz
Trustee (thru 11/15)2.01.0Yes (X)$18,000$0$0
Mark T Schieble
Trustee2.01.0Yes (X)$21,000$0$0
Steven L Seiler
Trustee (thru 4/15)3.00.0Yes (X)$5,250$0$0
Richard G Spurlock
Trustee2.00.0Yes (X)$21,000$0$0
Paul E Stander MD
Trustee2.00.0Yes (X)$20,000$0$0
Ron Waeckerlin MD
Trustee/Vice Chair3.01.0Yes (X)$36,000$0$0Yes (X)
Gary K Wilde
Trustee/Secretary/Treasurer3.01.0Yes (X)$25,250$0$0Yes (X)
Nancy L Wollen
Trustee (as of 11/15)2.01.0Yes (X)$0$0$0
J Daniel Connor
President/CEO38.02.0$672,854$0$39,344Yes (X)
Susan Barnes
Executive VP and CFO30.020.0$716,067$0$21,092Yes (X)
David Green
Pres Blood Centers Division40.00.0$513,262$0$38,317Yes (X)
Bhavi Shah
EVP/General Counsel30.010.0$242,326$0$24,425Yes (X)
Ralph Vassallo
EVP Chief Med & Scient Offcr40.00.0$469,132$0$13,833Yes (X)
Mary Beth Bassett
EVP Chief Quality Officer40.00.0$436,023$0$35,518Yes (X)
Michael Busch MD
SVP Research & Scientific Prog40.00.0$423,100$0$38,845Yes (X)
Tom Choi
VP Inv Mngmt & Hosp Srvcs40.00.0$211,784$0$12,687Yes (X)
Vicki Finson
VP Corporate Integration40.00.0$224,204$0$18,497Yes (X)
Dennis Harpool
SVP Oper Policies & Processes40.00.0$229,445$0$20,775Yes (X)
Robert Hartmann
VP Info Technology40.00.0$241,477$0$23,306Yes (X)
Hany Kamel MD
VP Corporate Medical Director40.00.0$340,865$0$46,142Yes (X)
Linda Matthews
President BioCARE40.00.0$485,472$0$44,963Yes (X)
PETER MICHAELSON
VP HUMAN RESOURCES40.00.0$275,975$0$42,437Yes (X)
Connie L Morris
VP Manufacturing & Lab Srvs40.00.0$180,532$0$20,480Yes (X)
Phillip Norris
VP Research & Scientific Prog40.00.0$259,474$0$41,056Yes (X)
Frank Nizzi MD
VP Clinical Services40.00.0$330,851$0$20,741Yes (X)
Paula Villalobos
VP Field Operations40.00.0$234,534$0$12,591Yes (X)
Charles E Wilcox III
VP Ops/Blood Centers Division40.00.0$263,394$0$20,688Yes (X)
Kevin Land MD
Sr Medical Director40.00.0$320,414$0$20,567Yes (X)
Andrew Kirk
vp sales40.00.0$281,984$0$32,785Yes (X)
pedro cano MD
sr medical DIR (thru 12/2015)40.00.0$277,433$0$8,917Yes (X)
ROBIN CUSICK
CHIEF MEDICAL OFFICER40.00.0$272,590$0$30,661Yes (X)
MARY TOWNSEND MD
SR MEDICAL DIRECTOR40.00.0$272,349$0$33,256Yes (X)
Patrick Holt
EVP Business Services40.00.0$358,730$0$0Yes (X)
SALLY CAGLIOTI
PRESIDENT CTS0.040.0$0$1,089,016$36,623Yes (X)
EUGENE Robertson PHD
VICE PRESIDENT CTS0.00.0$0$195,212$34,206Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$9,001,021TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$1,284,228TotReportableCompRltdOrgAmt
Total Other Compensation$732,752TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K200IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedYes (true)FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
Manpower Inc
21271 NETWORK PLaceCHICAGOIL60673CONSULTANT$2,247,096
mak systems
2720 river road suite 225DES PLAINESIL60018CONSULTANT$1,710,824
aerotek
2689 collections center wayCHICAGOIL60693CONSULTANT$1,353,849
TOLIN MECHANICAL SYSTEMS COMPANY
12005 EAST 45TH AVENUEDENVERCO80239MAINTENANCE SERVICE$1,181,359
Federal Express
PO Box 7221PASADENACA91109DELIVERY SERVICE$1,071,651
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K49CntrctRcvdGreaterThan100KCnt
Info In Schedule O Part VIIIYes (X)InfoInScheduleOPartVIIIInd
Federated Campaigns$5,576FederatedCampaignsAmt
Fundraising$130,716FundraisingAmt
Related Organizations$2,041,311RelatedOrganizationsAmt
All Other Contributions$5,444,463AllOtherContributionsAmt
Noncash Contributions$5,294,229NoncashContributionsAmt
Total Contributions$7,622,066TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (5 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmt
PHARMACEUTICAL SALES446110$305,092,002$133,333,021$171,758,981
BLOOD AND COMPONENTS SERVICE FEES541900$235,845,924$235,845,924
PLASMA FOR FRACTIONATION541900$12,791,492$12,791,492
LABORATORY SERVICES621500$12,623,283$12,623,283
RESEARCH CONTRACTS541700$10,718,774$10,718,774

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,576,547TotalRevenueColumnAmt
Related Or Exempt Func Income$1,576,547RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$578,648,022TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$3,211,529TotalRevenueColumnAmt
Exclusion$3,211,529ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$21,020TotalRevenueColumnAmt
Exclusion$21,020ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$178,138,226SecuritiesAmt
Other-$18,797OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$132,691,839SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$45,446,387SecuritiesAmt
Other-$18,797OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$45,427,590TotalRevenueColumnAmt
Exclusion$45,427,590ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$27,808FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$130,716ContriRptFundraisingEventAmt
Fundraising Direct Expenses$144,185FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$116,377TotalRevenueColumnAmt
Exclusion-$116,377ExclusionAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
MISCELLANEOUS INCOME900099$3,827,077$3,827,077
NON-OPERATING MISCELLANEOUS INCOME900099$1,259,535$1,259,535
FieldValueIRS element (for citing)
Other Revenue Total$5,086,612OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$639,900,462TotalRevenueColumnAmt
Related Or Exempt Func Income$411,975,653RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$171,758,981UnrelatedBusinessRevenueAmt
Exclusion$48,543,762ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$226,593TotalAmt
Program Services$226,593ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$7,279,713TotalAmt
Management And General$7,279,713ManagementAndGeneralAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$506,438TotalAmt
Program Services$89,686ProgramServicesAmt
Management And General$416,752ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$125,061,605TotalAmt
Program Services$107,310,387ProgramServicesAmt
Management And General$17,751,218ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$9,283,416TotalAmt
Program Services$10,647,772ProgramServicesAmt
Management And General-$1,364,356ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$20,657,955TotalAmt
Program Services$16,348,051ProgramServicesAmt
Management And General$4,309,904ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$8,807,559TotalAmt
Program Services$6,740,552ProgramServicesAmt
Management And General$2,067,007ManagementAndGeneralAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$665,633TotalAmt
Management And General$665,633ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$500,983TotalAmt
Management And General$500,983ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$117,887TotalAmt
Management And General$117,887ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$4,204,746TotalAmt
Program Services$1,312,227ProgramServicesAmt
Management And General$2,892,519ManagementAndGeneralAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$174,352TotalAmt
Program Services$174,352ProgramServicesAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$16,601,386TotalAmt
Program Services$12,634,089ProgramServicesAmt
Management And General$3,967,297ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$3,738,277TotalAmt
Program Services$9,025,124ProgramServicesAmt
Management And General-$5,286,847ManagementAndGeneralAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$12,353,916TotalAmt
Program Services$11,156,867ProgramServicesAmt
Management And General$1,197,049ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$11,381,128TotalAmt
Program Services$9,048,813ProgramServicesAmt
Management And General$2,332,315ManagementAndGeneralAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$1,863,717TotalAmt
Program Services$1,142ProgramServicesAmt
Management And General$1,862,575ManagementAndGeneralAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$14,690,688TotalAmt
Program Services$6,440,972ProgramServicesAmt
Management And General$8,249,716ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$1,234,238TotalAmt
Program Services$876,489ProgramServicesAmt
Management And General$357,749ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmt
PHARM. PRODUCTS PURCHASED$286,890,074$286,890,074
OPERATING & TESTING SUPPLIES$76,880,957$76,880,957
DONOR RECOGNITION & PROMO$9,787,803$9,787,803
INCOME TAX$35,950$35,950

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total-$3,816,602TotalAmt
Program Services$15,254,487ProgramServicesAmt
Management And General-$19,071,089ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$609,128,412TotalAmt
Program Services$580,882,387ProgramServicesAmt
Management And General$28,246,025ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY-$8,639,484EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$126,392,934BOYAmt
EOY$87,351,623EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$80,644,268BOYAmt
EOY$122,779,113EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$150,000BOYAmt
EOY$125,000EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$6,863,645BOYAmt
EOY$5,983,051EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$61,649,285BOYAmt
EOY$69,301,188EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$8,842,694BOYAmt
EOY$6,527,770EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$205,420,753LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$139,306,659LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$79,235,672BOYAmt
EOY$66,114,094EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$27,081,572BOYAmt
EOY$25,097,431EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$9,290,011BOYAmt
EOY$6,743,105EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$480,000BOYAmt
EOY$360,000EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$1,000,874BOYAmt
EOY$777,460EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$401,630,955BOYAmt
EOY$382,520,351EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$106,814,464BOYAmt
EOY$107,239,610EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$26,175,000BOYAmt
EOY$23,620,000EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$23,417,911BOYAmt
EOY$16,014,465EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$43,708,563BOYAmt
EOY$45,151,954EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$200,115,938BOYAmt
EOY$192,026,029EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$201,515,017BOYAmt
EOY$190,494,322EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$201,515,017BOYAmt
EOY$190,494,322EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$401,630,955BOYAmt
EOY$382,520,351EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$30,772,050ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$50,846,004NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts$847,773DonatedServicesAndUseFcltsAmt
Other Changes In Net Assets$8,205,486OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredYes (true)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (true)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Publicly Supported Org509a2Yes (X)PubliclySupportedOrg509a2Ind

Gifts Grants Contris Rcvd509 GiftsGrantsContrisRcvd509Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$7,850,022CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$9,272,139CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$8,382,904CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$8,365,565CurrentTaxYearMinus1YearAmt
Current Tax Year$7,622,066CurrentTaxYearAmt
Total$41,492,696TotalAmt

Gross Receipts Admissions GrossReceiptsAdmissionsGrp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$485,095,730CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$483,844,494CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$476,310,348CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$488,608,480CurrentTaxYearMinus1YearAmt
Current Tax Year$583,584,663CurrentTaxYearAmt
Total$2,517,443,715TotalAmt

Gross Receipts Non Unrlt Bus GrossReceiptsNonUnrltBusGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Tax Rev Levied Orgnztnl Bnft509 TaxRevLeviedOrgnztnlBnft509Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl509 GovtFurnSrvcFcltsVl509Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total509 Total509Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$492,945,752CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$493,116,633CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$484,693,252CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$496,974,045CurrentTaxYearMinus1YearAmt
Current Tax Year$591,206,729CurrentTaxYearAmt
Total$2,558,936,411TotalAmt

Amounts Rcvd Dsqlfy Person AmountsRcvdDsqlfyPersonGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Substantial Contributors Amt SubstantialContributorsAmtGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Subst And Dsqlfy Prsns Tot SubstAndDsqlfyPrsnsTotGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
FieldValueIRS element (for citing)
Public Support Total509$2,558,936,411PublicSupportTotal509Amt

Gross Investment Income509 GrossInvestmentIncome509Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$4,163,810CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$3,987,530CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,621,490CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$4,295,796CurrentTaxYearMinus1YearAmt
Current Tax Year$3,232,549CurrentTaxYearAmt
Total$19,301,175TotalAmt

Post1975 UBTI Post1975UBTIGrp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$15,544CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$47,343CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$67,686CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$47,439CurrentTaxYearMinus1YearAmt
Current Tax Year$74,585CurrentTaxYearAmt
Total$252,597TotalAmt

Investment Income And UBTI InvestmentIncomeAndUBTIGrp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$4,179,354CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$4,034,873CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,689,176CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$4,343,235CurrentTaxYearMinus1YearAmt
Current Tax Year$3,307,134CurrentTaxYearAmt
Total$19,553,772TotalAmt

Net Income From Other UBI NetIncomeFromOtherUBIGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income509 OtherIncome509Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Support Calendar Year TotalSupportCalendarYearGrp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$497,125,106CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$497,151,506CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$488,382,428CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$501,317,280CurrentTaxYearMinus1YearAmt
Current Tax Year$594,513,863CurrentTaxYearAmt
Total$2,578,490,183TotalAmt
FieldValueIRS element (for citing)
Public Support CY5090.99242PublicSupportCY509Pct
Public Support PY5090.99226PublicSupportPY509Pct
Investment Income CY0.00758InvestmentIncomeCYPct
Investment Income PY0.00773InvestmentIncomePYPct
Thirty Thr Pct Suprt Tests CY509Yes (X)ThirtyThrPctSuprtTestsCY509Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$26,960,483BeginningYearBalanceAmt
Contributions$483ContributionsAmt
Investment Earnings Or Losses-$561,129InvestmentEarningsOrLossesAmt
Other Expenditures$1,302,406OtherExpendituresAmt
End Year Balance$25,097,431EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$29,650,105BeginningYearBalanceAmt
Investment Earnings Or Losses$1,268,538InvestmentEarningsOrLossesAmt
Other Expenditures$3,958,160OtherExpendituresAmt
End Year Balance$26,960,483EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$27,010,166BeginningYearBalanceAmt
Investment Earnings Or Losses$3,712,762InvestmentEarningsOrLossesAmt
Other Expenditures$1,072,823OtherExpendituresAmt
End Year Balance$29,650,105EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$25,294,973BeginningYearBalanceAmt
Investment Earnings Or Losses$2,769,261InvestmentEarningsOrLossesAmt
Other Expenditures$1,044,881OtherExpendituresAmt
Administrative Expenses$9,187AdministrativeExpensesAmt
End Year Balance$27,010,166EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$21,171,221BeginningYearBalanceAmt
Contributions$4,060,473ContributionsAmt
Investment Earnings Or Losses$68,277InvestmentEarningsOrLossesAmt
Other Expenditures$0OtherExpendituresAmt
Administrative Expenses$4,998AdministrativeExpensesAmt
End Year Balance$25,294,973EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY1.00000BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.00000PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.00000TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd

Land LandGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$6,802,117OtherCostOrOtherBasisAmt
Book Value$6,802,117BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$62,013,050OtherCostOrOtherBasisAmt
Depreciation$40,160,406DepreciationAmt
Book Value$21,852,644BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$14,003,819OtherCostOrOtherBasisAmt
Depreciation$12,510,239DepreciationAmt
Book Value$1,493,580BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$69,647,071OtherCostOrOtherBasisAmt
Depreciation$57,807,724DepreciationAmt
Book Value$11,839,347BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$52,954,696OtherCostOrOtherBasisAmt
Depreciation$28,828,290DepreciationAmt
Book Value$24,126,406BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$66,114,094TotalBookValueLandBuildingsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (3 entries)

DescDescAmtAmt
CURRENT LINE OF CREDIT$45,000,000
LONG TERM RENT STEP UP$147,296
LT TENANT IMPROVEMENT ALLOWANCE$4,658
FieldValueIRS element (for citing)
Total Liability$45,151,954TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
SCHEDULE D, PART V, LINE 4THE BLOOD SYSTEMS BOARD RESTRICTED ENDOWMENT FUNDS ARE RESERVED FOR THE PURPOSES OF PROVIDING RESEARCH FUNDS TO BLOOD SYSTEMS RESEARCH INSTITUTE TO SUPPORT THE BLOOD TRANSFUSION RESEARCH EFFORTS OF THAT DIVISION.
SCHEDULE D, PART X, LINE 2AT DECEMBER 31, 2015, THE COMPANY EVALUATED WHETHER IT HAD UNCERTAIN TAX POSITIONS THAT SHOULD BE RECOGNIZED OR DERECOGNIZED BASED ON A 'MORE LIKELY THAN NOT' THRESHOLD FOR TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING THOSE TAX POSITIONS THAT WOULD NOT BE SUSTAINED UPON EXAMINATION IN ACCORDANCE WITH GUIDANCE RELATED TO ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. THE TAX YEARS FOR THE COMPANY THAT ARE OPEN TO AUDIT BY THE IRS AND STATE DEPARTMENTS OF REVENUE ARE GENERALLY THE TAX YEARS ENDED DECEMBER 31, 2012, THROUGH THE CURRENT TAX YEAR EXCEPT IN CERTAIN STATES WHERE THE OPEN TAX YEARS GENERALLY BEGIN WITH THE TAX YEAR ENDED DECEMBER 31, 2011. AS OF DECEMBER 31, 2015, THE COMPANY HAS NOT IDENTIFIED ANY UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE THE RECORDING OF A TAX LIABILITY. THE COMPANY DOES NOT ANTICIPATE A CHANGE IN UNCERTAIN TAX POSITIONS FOR THE 12 MONTHS FOLLOWING THE YEAR ENDED DECEMBER 31, 2015.

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp

FieldValueIRS element (for citing)
RegionCentral America and the CaribbeanRegionTxt
Type Of Activities ConductedProgram ServicesTypeOfActivitiesConductedTxt
Specific Services ProvidedCAPTIVE INSURANCESpecificServicesProvidedTxt
Region Total Expenditures$534,761RegionTotalExpendituresAmt
FieldValueIRS element (for citing)
Subtotal Spent$534,761SubtotalSpentAmt
Total Spent$534,761TotalSpentAmt
Transfer To Foreign CorpYes (true)TransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipYes (true)ForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1GALAEvent1Nm
Gross Receipts Event1$80,094GrossReceiptsEvent1Amt
Charitable Contri Event1$74,017CharitableContriEvent1Amt
Gross Revenue Event1$6,077GrossRevenueEvent1Amt
Non Cash Prizes Event1$17,645NonCashPrizesEvent1Amt
Food And Beverage Event1$10,682FoodAndBeverageEvent1Amt
Entertainment Event1$25,000EntertainmentEvent1Amt
Other Direct Expenses Event1$15,978OtherDirectExpensesEvent1Amt
Event2LUNCHEONEvent2Nm
Gross Receipts Event2$36,219GrossReceiptsEvent2Amt
Charitable Contri Event2$24,459CharitableContriEvent2Amt
Gross Revenue Event2$11,760GrossRevenueEvent2Amt
Rent Facility Costs Event2$27,366RentFacilityCostsEvent2Amt
Food And Beverage Event2$7,000FoodAndBeverageEvent2Amt
Other Direct Expenses Event2$22,479OtherDirectExpensesEvent2Amt
Other Events Total2OtherEventsTotalCnt
Gross Receipts Other Events$42,211GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$32,240CharitableContriOtherEventsAmt
Gross Revenue Other Events$9,971GrossRevenueOtherEventsAmt
Non Cash Prizes Other Events$2,345NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events$3,009RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events$3,009FoodAndBeverageOtherEventsAmt
Oth Direct Expnss Other Events$9,672OthDirectExpnssOtherEventsAmt
Gross Receipts Total$158,524GrossReceiptsTotalAmt
Charitable Contributions Tot$130,716CharitableContributionsTotAmt
Gross Revenue Total Events$27,808GrossRevenueTotalEventsAmt
Non Cash Prizes Total Events$19,990NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events$30,375RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$20,691FoodAndBeverageTotalEventsAmt
Entertainment Total Events$25,000EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$48,129OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$144,185DirectExpenseSummaryEventsAmt
Net Income Summary-$116,377NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (4 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
AMERICA'S BLOOD CENTERS
725 15TH STR NW STE 700WASHINGTONDC200052100866052376501(C)(6)$27,5002015 PLEDGE Support
AMERICAN ASSOCIATION OF BLOOD BANKS
8101 GLENBROOK ROADBETHESDAMD20814362384118501(C)(3)$75,000CORD BLOOD PLEDGE
GLOBAL BLOOD FUND
1001 N LINCOLN BLVDOKLAHOMA CITYOK73104392071848501(C)(3)$10,0002015 PLEDGE Support
FLIGHTS FOR LIFE
PO BOX 26485PHOENIXAZ85068742453899501(C)(3)$16,000General Support
FieldValueIRS element (for citing)
Total501c3 Org3Total501c3OrgCnt
Total Other Org1TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE I, PART I, LINE 2FormAndLineReferenceDesc
ExplanationSPONSORSHIPS AND DONATIONS TO OTHER TAX-EXEMPT ENTITIES ARE MADE IN SUPPORT OF THEIR MISSIONS AND ARE MONITORED VIA THE GOVERNANCE PRACTICES OF THOSE ENTITIES.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentYes (true)SeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (true)SupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (true)AnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (27 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
J Daniel Connor
President/CEO$660,704$0$0$0$12,150$0$28,600$0$10,744$0$712,198$0$0$0
Susan Barnes
Executive VP and CFO$320,595$0$0$0$395,472$0$10,600$0$10,492$0$737,159$0$384,361$0
David Green
Pres Blood Centers Division$394,091$0$61,875$0$57,296$0$23,364$0$14,953$0$551,579$0$0$0
Bhavi Shah
EVP/General Counsel$216,214$0$15,000$0$11,112$0$10,113$0$14,312$0$266,751$0$0$0
Mary Beth Bassett
EVP Chief Quality Officer$298,959$0$125,000$0$12,064$0$28,600$0$6,918$0$471,541$0$952$0
Michael Busch MD
SVP Research & Scientific Prog$408,868$0$0$0$14,232$0$28,600$0$10,245$0$461,945$0$4,263$0
Tom Choi
VP Inv Mngmt & Hosp Srvcs$201,815$0$0$0$9,969$0$6,352$0$6,335$0$224,471$0$0$0
Vicki Finson
VP Corporate Integration$223,466$0$0$0$738$0$8,086$0$10,411$0$242,701$0$0$0
Dennis Harpool
SVP Oper Policies & Processes$219,476$0$0$0$9,969$0$3,716$0$17,059$0$250,220$0$0$0
Robert Hartmann
VP Info Technology$231,508$0$0$0$9,969$0$9,489$0$13,817$0$264,783$0$0$0
Hany Kamel MD
VP Corporate Medical Director$328,916$0$0$0$11,949$0$28,600$0$17,542$0$387,007$0$1,980$0
Linda Matthews
President BioCARE$300,364$0$170,464$0$14,644$0$28,600$0$16,363$0$530,435$0$3,532$0
PETER MICHAELSON
VP HUMAN RESOURCES$266,006$0$0$0$9,969$0$28,600$0$13,837$0$318,412$0$0$0
Connie L Morris
VP Manufacturing & Lab Srvs$170,563$0$0$0$9,969$0$6,849$0$13,631$0$201,012$0$0$0
Phillip Norris
VP Research & Scientific Prog$259,474$0$0$0$0$0$27,681$0$13,375$0$300,530$0$0$0
Frank Nizzi MD
VP Clinical Services$320,882$0$0$0$9,969$0$10,600$0$10,141$0$351,592$0$0$0
Ralph Vassallo
EVP Chief Med & Scient Offcr$341,680$0$15,000$0$112,452$0$7,950$0$5,883$0$482,965$0$0$0
Paula Villalobos
VP Field Operations$224,565$0$0$0$9,969$0$6,181$0$6,410$0$247,125$0$0$0
Charles E Wilcox III
VP Ops/Blood Centers Division$253,425$0$0$0$9,969$0$10,600$0$10,088$0$284,082$0$0$0
Patrick Holt
EVP Business Services$57,725$0$0$0$301,005$0$0$0$0$0$358,730$0$0$0
Kevin Land MD
Sr Medical Director$320,414$0$0$0$0$0$6,686$0$13,881$0$340,981$0$0$0
Andrew Kirk
vp sales$141,614$0$88,385$0$51,985$0$7,078$0$25,707$0$314,769$0$0$0
pedro cano MD
sr medical DIR (thru 12/2015)$265,984$0$0$0$11,449$0$7,950$0$967$0$286,350$0$0$0
ROBIN CUSICK
CHIEF MEDICAL OFFICER$272,590$0$0$0$0$0$28,500$0$2,161$0$303,251$0$0$0
MARY TOWNSEND MD
SR MEDICAL DIRECTOR$272,349$0$0$0$0$0$10,600$0$22,656$0$305,605$0$0$0
SALLY CAGLIOTI
PRESIDENT CTS$0$364,615$0$96,980$0$627,421$0$28,600$0$8,023$0$1,125,639$0$616,309
EUGENE Robertson PHD
VICE PRESIDENT CTS$0$122,561$0$68,220$0$4,431$0$25,689$0$8,517$0$229,418$0$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
SCHEDULE J, PART I, LINE 4aPATRICK HOLT received severance payments of $300,593 during 2015. This amount is taxable and is included in Schedule J, Part II, Column b(III). SCHEDULE J, PART I, LINE 4B CERTAIN EMPLOYEES RECEIVED DISTRIBUTIONS FROM THE SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN DURING 2015 AS FOLLOWS: SALLY CAGLIOTI: $616,309 (RESULTING FROM ALMOST 27 YEARS OF SERVICE) MARY BETH BASSETT: $952 (RESULTING FROM ALMOST 20 YEARS OF SERVICE) MICHAEL BUSCH, MD: $4,263 (RESULTING FROM ALMOST 17 YEARS OF SERVICE) HANY KAMEL, MD: $1,980 (RESULTING FROM ALMOST 20 YEARS OF SERVICE) LINDA MATTHEWS: $3,532 (RESULTING FROM ALMOST 16 YEARS OF SERVICE) SUSAN L. BARNES: $384,361 (RESULTING FROM ALMOST 26 YEARS OF SERVICE) THESE AMOUNTS WERE INCLUDED IN TAXABLE WAGES AND ARE REPORTED IN SCHEDULE J, PART II, COLUMN B(III) AND ALSO IN COLUMN F SINCE THESE AMOUNTS HAVE PREVIOUSLY BEEN REPORTED AS DEFERRED COMPENSATION ON A PRIOR FORM 990. THIS PLAN WAS FROZEN AS OF DECEMBER 31, 2011.
SCHEDULE J, PART I, LINE 7BLOOD SYSTEMS HAS AN INCENTIVE BONUS PLAN FOR MANAGEMENT AND EXECUTIVES. AWARDS UNDER THE PROGRAM ARE AT THE DISCRETION OF THE BOARD OF TRUSTEES. THE PLAN MEASURES PERFORMANCE AGAINST MULTIPLE METRICS WHICH CARRY VARIOUS WEIGHTINGS, THE MOST HEAVILY WEIGHTED BEING QUALITY, SAFETY AND CUSTOMER SERVICE. TO ASSURE FINANCIAL STABILITY OF THE COMPANY, ONE OF THE METRICS IS ALSO A MEASUREMENT OF NET MARGIN FINANCIAL PERFORMANCE AS A PERCENT OF REVENUES.
SCHEDULE J, PART IIDavid Green, Ralph Vassallo, Andrew Kirk and Pedro Cano received payments for relocation expenses. This amount is taxable and is included in Schedule J, Part II, Column B(III). DAVID GREEN, BHAVI SHAH, RALPH VASSALLO, AND ANDREW KIRK RECIEVED HIRING BONUSES, WHICH ARE INCLUDED IN SCHEDULE J, PART II, COLUMN B(II). MARY BETH BASSETT RECIEVED A RETRENTION BONUS, WHICH IS INCLUDED IN SCHEDULE J, PART II, COLUMN B(II). LINDA MATTHEWS IS THE PRESIDENT OF THE BIOCARE DIVISION OF BLOOD SYSTEMS. THIS DIVISION PERFORMED WELL ABOVE ITS BUDGETED EXPECTATION AND WAS GRANTED AN INCENTIVE BONUS UNDER THE COMPANY'S PLAN.

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd

Issuer Name IssuerName

FieldValueIRS element (for citing)
Business Name Line1ARIZONA HEALTH FACILITIES AUTHORITYBusinessNameLine1Txt
FieldValueIRS element (for citing)
Bond Issuer EIN860453292BondIssuerEIN
Bond Issued2014-01-06BondIssuedDt
Issue Price$27,005,000IssuePriceAmt
PurposeSEE PART VIPurposeDesc
DefeasedfalseDefeasedInd
On Behalf Of IssuerfalseOnBehalfOfIssuerInd
Pool FinancingfalsePoolFinancingInd

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Retired$3,385,000RetiredAmt
Bond Defeased$0BondDefeasedAmt
Total Proceeds$27,005,000TotalProceedsAmt
In Reserve Fund$0InReserveFundAmt
Capitalized Interest$0CapitalizedInterestAmt
Refunding Escrow$0RefundingEscrowAmt
Issuance Costs From Proceeds$41,114IssuanceCostsFromProceedsAmt
Credit Enhancement$0CreditEnhancementAmt
Working Capital Expenditures$0WorkingCapitalExpendituresAmt
Capital Expenditures$26,963,886CapitalExpendituresAmt
Other Spent Proceeds$0OtherSpentProceedsAmt
Unspent$0UnspentAmt
Substantial Completion2014SubstantialCompletionYr
Current RefundingYes (true)CurrentRefundingInd
Advance RefundingfalseAdvanceRefundingInd
Final Allocation MadeYes (true)FinalAllocationMadeInd
Adequate Books And Rec MaintYes (true)AdequateBooksAndRecMaintInd

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Owning Bond Financed PropertyfalseOwningBondFinancedPropertyInd
Any Lease ArrangementsfalseAnyLeaseArrangementsInd
Mgmt Contract Bond Fincd PropfalseMgmtContractBondFincdPropInd
Any Research AgreementsYes (true)AnyResearchAgreementsInd
Engage Bond Counsel ResearchfalseEngageBondCounselResearchInd
Private Bus Use By Others0.00000PrivateBusUseByOthersPct
Private Bus Concerning UBI0.00700PrivateBusConcerningUBIPct
Total Private Business Use0.00700TotalPrivateBusinessUsePct
Bond Iss Meet Prvt Sec Pymt TestfalseBondIssMeetPrvtSecPymtTestInd
Change In Use Bond Financed PropfalseChangeInUseBondFinancedPropInd
Change In Use Bond Financed Prop0.00000ChangeInUseBondFinancedPropPct
Remedial Action TakenfalseRemedialActionTakenInd
Procs Nonqualified Bond RemdtdYes (true)ProcsNonqualifiedBondRemdtdInd

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Form8038 T FiledfalseForm8038TFiledInd
Exception To RebateYes (true)ExceptionToRebateInd
Variable Rate IssuefalseVariableRateIssueInd
Hedge Identified In Bks And RecfalseHedgeIdentifiedInBksAndRecInd

Hedge Provider Name HedgeProviderName

FieldValueIRS element (for citing)
Business Name Line10BusinessNameLine1Txt
FieldValueIRS element (for citing)
Gross Proceeds Invested In GICfalseGrossProceedsInvestedInGICInd

GIC Provider Name GICProviderName

FieldValueIRS element (for citing)
Business Name Line10BusinessNameLine1Txt
FieldValueIRS element (for citing)
Gross Proceeds InvestedfalseGrossProceedsInvestedInd
Written Proc To Monitor ReqsYes (true)WrittenProcToMonitorReqsInd

Procedures Corrective Action ProceduresCorrectiveActionGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Procedures Corrective ActionYes (true)ProceduresCorrectiveActionInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line Reference.FormAndLineReferenceDesc
ExplanationSchedule K, Part I, Line A, Column F REFUNDING OF AHFA 2004 BOND ISSUE WHICH WAS USED FOR THE PURCHASE OF LAND AND TO CONSTRUCT AND EQUIP 11 BLOOD CENTERS IN VARIOUS STATES FOR THE PURPOSE OF RECRUITING, COLLECTING, PROCESSING AND DISTRIBUTING BLOOD PRODUCTS; REFUNDING OF ABAG 2002 BOND ISSUE USED TO CONSTRUCT A BLOOD CENTER IN SAN FRANCISCO, CA; AND, REFUNDING OF AHFA 1995 VARIABLE RATE BOND ISSUE USED TO CONSTRUCT AND EQUIP A NATIONAL BLOOD TESTING LABORATORY IN TEMPE, ARIZONA.ExplanationTxt

Schedule L IRS990ScheduleL

Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp

FieldValueIRS element (for citing)
PersonDAVID GREENPersonNm
Relationship With OrgOFFICERRelationshipWithOrgTxt
Loan PurposeHOUSELoanPurposeTxt
Loan From OrganizationYes (X)LoanFromOrganizationInd
Original Principal$150,000OriginalPrincipalAmt
Balance Due$125,000BalanceDueAmt
DefaultfalseDefaultInd
Board Or Committee ApprovalYes (true)BoardOrCommitteeApprovalInd
Written AgreementYes (true)WrittenAgreementInd
FieldValueIRS element (for citing)
Total Balance Due$125,000TotalBalanceDueAmt

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp

Name Of Interested NameOfInterested

FieldValueIRS element (for citing)
Personorrin h campPersonNm
FieldValueIRS element (for citing)
Relationship Descriptionspouse of officerRelationshipDescriptionTxt
Transaction$89,686TransactionAmt
TransactionCOMPENSATION - BSI EMPLOYEETransactionDesc
Sharing Of RevenuesfalseSharingOfRevenuesInd

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp
Clothing And Household GoodsClothingAndHouseholdGoodsGrp
Cars And Other VehiclesCarsAndOtherVehiclesGrp
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp
Securities Publicly TradedSecuritiesPubliclyTradedGrp
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp
Food InventoryFoodInventoryGrp
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp

Other Non Cash Contri Table OtherNonCashContriTableGrp (3 entries)

Non Cash CheckboxNonCashCheckboxIndDescDescContributionContributionCntNoncash Contributions Rpt F990NoncashContributionsRptF990AmtMethod Of Determining RevenuesMethodOfDeterminingRevenuesTxt
Yes (X)RECOGNITION352$5,275,493COST/SELLING PRICE
Yes (X)REFRESHMENT63$18,313COST/SELLING PRICE
Yes (X)OTHER4$423COST/SELLING PRICE
FieldValueIRS element (for citing)
Form8283 Received0Form8283ReceivedCnt
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE M, PART I, COLUMN (B)FormAndLineReferenceDesc
ExplanationTHE ORGANIZATION IS REPORTING THE NUMBER OF CONTRIBUTIONS RECEIVED IN COLUMN (B).ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (10 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART III, LINE 1THE MISSION OF BLOOD SYSTEMS, INC. ("BSI") IS TO MAKE A DIFFERENCE IN PEOPLE'S LIVES BY BRINGING TOGETHER THE BEST PEOPLE, INSPIRING INDIVIDUALS TO DONATE BLOOD, PRODUCING A SAFE AND AMPLE BLOOD SUPPLY, ADVANCING CUTTING-EDGE RESEARCH AND EMBRACING CONTINUOUS QUALITY IMPROVEMENT. TO FURTHER ITS MISSION, BSI OPERATES 17 COMMUNITY BLOOD CENTERS. THESE CENTERS RECRUIT BLOOD DONORS AND COLLECT, PROCESS AND DISTRIBUTE APPROXIMATELY 860,000 BLOOD DONATIONS TO MEET THE BLOOD NEEDS OF PATIENTS IN MORE THAN 500 HOSPITALS THROUGHOUT THE COUNTRY. THE STAFF OF NEARLY 2,300 SERVES A GEOGRAPHIC AREA COVERING THE UNITED STATES, FROM THE EAST COAST TO CALIFORNIA AND FROM THE CANADIAN BORDER TO MEXICO. BSI IS KNOWN MORE COMMONLY THROUGHOUT THE UNITED STATES BY THE NAME OF ITS BLOOD BANKING DIVISION, UNITED BLOOD SERVICES. BSI IS LICENSED BY THE U.S. FOOD AND DRUG ADMINISTRATION ("FDA") AS A PROVIDER OF BLOOD AND BLOOD SERVICES. THE COMPANY'S THREE OPERATING DIVISIONS ARE: (1) THE BLOOD BANKING DIVISION, WHICH INCLUDES UNITED BLOOD SERVICES; (2) THE BIOCARE DIVISION; AND (3) THE BLOOD SYSTEMS RESEARCH INSTITUTE. THESE OPERATING DIVISIONS ARE UNINCORPORATED DIVISIONS DOING BUSINESS UNDER REGISTERED TRADENAMES AND SERVICE MARKS. BSI CONDUCTS ITS BLOOD BANKING ACTIVITIES THROUGH ITS REGIONAL BLOOD CENTERS LOCATED IN THE FOLLOWING STATES: ARIZONA, CALIFORNIA, COLORADO, LOUISIANA, MISSISSIPPI, MONTANA, NEVADA, NEW MEXICO, NORTH DAKOTA, SOUTH DAKOTA, TEXAS, OHIO, NEW JERSEY, AND WYOMING. THE BIOCARE DIVISION DISTRIBUTES PLASMA-DERIVED PRODUCTS THROUGH HOSPITALS, COMMUNITY BLOOD CENTER LOCATIONS AND ALSO DIRECTLY FROM ITS HEADQUARTERS IN TEMPE, ARIZONA. BLOOD-RELATED RESEARCH IS CONDUCTED AT THE BLOOD SYSTEMS RESEARCH INSTITUTE LOCATED IN SAN FRANCISCO, CALIFORNIA. FORM 990, PART III, LINE 2 ON JANUARY 1, 2015 BSI EFFECTED A MEMBER SUBSTITUTION (ACQUIRED) WITH LIFESHARE COMMUNITY BLOOD SERVICES, INC ("lIFESHARE"). LIFESHARE IS A COMMUNITY-FOCUSED NONPROFIT ORGANIZATION COMMITTED TO PROVIDING A SAFE AND ADEQUATE BLOOD SUPPLY AND COMPONENT SUPPLY FOR PATIENT HEALTHCARE IN NORTHEAST OHIO. ON FEBRUARY 1, 2015 BSI EFFECTED A MEMBER SUBSTITUTION (ACQUIRED) WITH BERGEN COMMUNITY REGIONAL BLOOD CENTER, INC ("cOMMUNITY BLOOD SERVICES"). COMMUNITY BLOOD SERVICES PROMOTeS THE HEALTH OF THE COMMUNITY BY PROVIDING HIGH-QUALITY BLOOD AND TISSUE SERVICES. ON NOVEMBER 1, 2015 BSI EFFECTED A MEMBER SUBSTITUTION (ACQUIRED) WITH MID-SOUTH REGIONAL BLOOD CENTER, INC ("MID-SOUTH"). MID-SOUTH IS A COMMUNITY-FOCUSED NONPROFIT ORGANIZATION COMMITTED TO PROVIDING A SAFE AND ADEQUATE BLOOD SUPPLY FOR PATIENT HEALTHCARE IN THE MID-SOUTH REGION.
FORM 990, PART III, LINES 4A-D4A) UNITED BLOOD SERVICES - BLOOD BANKING THE BLOOD BANKING DIVISION OPERATES UNDER THE NAME UNITED BLOOD SERVICES ("UBS"). THE PRIMARY PURPOSE OF UBS IS TO PROVIDE A SAFE AND STABLE SUPPLY OF BLOOD AND BLOOD COMPONENTS TO HOSPITALS AND MEDICAL FACILITIES. THE STRENGTH OF UBS IS THAT IT OPERATES AS LOCAL BLOOD CENTERS THAT ARE PART OF THE COMMUNITY AND YET HAS ACCESS TO A LARGE NETWORKED ORGANIZATION WITH ALL THE ADVANTAGES AND EFFICIENCIES THAT ARE REALIZED THROUGH STANDARDIZATION AND ECONOMIES OF SCALE. UBS COLLECTS BLOOD FROM VOLUNTEER DONORS, PERFORMS SCREENING AND TESTING ON THE DONATED BLOOD, AND PROCESSES THE WHOLE BLOOD INTO BLOOD COMPONENTS SUCH AS RED CELLS, PLATELETS AND PLASMA. BLOOD AND BLOOD COMPONENTS ARE THEN STORED AND DISTRIBUTED TO HOSPITALS AND OTHER HEALTH CARE PROVIDERS. 4B) BIOCARE - BIOLOGICALS THE BIOCARE DIVISION PROVIDES BIOLOGICAL PRODUCTS, BOTH HUMAN-PLASMA DERIVED AND RECOMBINANT PRODUCTS, THAT SERVE AS ADJUNCT THERAPIES IN TRANSFUSION MEDICINE AND HEALTHCARE. PLASMA DERIVATIVES ARE BASICALLY PROTEIN THERAPIES PROVIDED FROM PLASMA LEFT OVER FROM WHOLE BLOOD DONATIONS. EXAMPLES OF SUCH PLASMA DERIVATIVES INCLUDE: INTRAVENOUS IMMUNE GLOBULINS, COAGULATION FACTORS, ALBUMIN AND FIBRIN SEALANTS. THESE PRODUCTS ARE USED AS THERAPIES FOR IMMUNE SYSTEM DISORDERS, BLEEDING DISORDERS AND WOUND MANAGEMENT. RECOMBINANT-BASED PRODUCTS ARE PRODUCTS THAT ARE NOT MADE FROM FRACTIONATED HUMAN PLASMA. INSTEAD, THESE PRODUCTS ARE GENETICALLY ENGINEERED. THE RESULTING PRODUCT HAS THE STRUCTURAL AND FUNCTIONAL CHARACTERISTICS SIMILAR TO THE COMPONENT FOUND IN HUMAN PLASMA (OR BASED ON A PROTEIN IN HUMAN PLASMA) THAT THE DRUG WAS SYNTHESIZED TO IMITATE. RECOMBINANT-BASED PRODUCTS ARE OFTEN STABILIZED WITH ALBUMIN (CONCENTRATE OF PLASMA PROTEINS FROM HUMAN PLASMA), BUT THESE PRODUCTS ARE NOT MANUFACTURED FROM HUMAN PLASMA. THESE RECOMBINANT PRODUCTS, SIMILAR TO THE PLASMA-DERIVATIVE PRODUCTS, ARE USED TO TREAT DISEASES AND MEDICAL CONDITIONS THAT ARE CONNECTED WITH OR RELATED TO BLOOD OR BLOOD-BORNE MEDICAL CONDITIONS. 4C) BLOOD SYSTEMS RESEARCH INSTITUTE BLOOD SYSTEMS RESEARCH INSTITUTE ("BSRI") FACILITATES RESEARCH PRIMARILY FUNDED BY EXTRAMURAL GRANTS (NIH AND OTHERS). THE RESEARCH IS IN TRANSFUSION MEDICINE EPIDEMIOLOGY, HEALTH POLICY, VIROLOGY, VIRAL DISCOVERY, THE IMMUNE REACTION TO TRANSFUSION AND TO TRANSFUSION-TRANSMITTED INFECTIOUS AGENTS, CELL THERAPY AND GENETIC EPIDEMIOLOGY. AREAS STUDIED INCLUDE IMPLICATIONS OF RECEIVING COMPONENTS AT DIFFERENT STORAGE AGES; MECHANISM OF VIRUS ENTRY INTO CELLS; HOW TRANSFUSION TRANSMITTED VIRUSES CAUSE SYMPTOMS; THE USE OF COMMERCIALLY AVAILABLE OR LOCALLY-DEVELOPED DONOR TESTS; THE FACTORS LEADING TO CHIMERISM, ETC. BSRI SUPPORTS TRAINING PROGRAMS FOR SPECIALISTS IN TRANSFUSION MEDICINE AND THE DEVELOPMENT OF EPIDEMIOLOGY RESEARCH SCIENTISTS. BSRI INVESTIGATORS PUBLISH MORE THAN 45 PAPERS EACH YEAR IN THE PEER-REVIEWED SCIENTIFIC LITERATURE. THE RESEARCH FACILITY IS STAFFED WITH 12 INVESTIGATORS, 24 RESEARCH ASSOCIATES, 16 STAFF SCIENTISTS AND VARIOUS OTHER POSITIONS AS WELL AS ADMINISTRATIVE SUPPORT. 4D) OTHER PROGRAM SERVICES CONSIST OF LABORATORY SERVICES AND OTHER PROGRAM ACTIVITIES.
FORM 990, PART VI, LINE 1ATHE EXECUTIVE COMMITTEE HAS THE POWERS OF THE BOARD OF TRUSTEES BETWEEN BOARD MEETINGS, UNLESS PROHIBITED BY LAW OR THE ARTICLES OF INCORPORATION. THE EXECUTIVE COMMITTEE IS COMPOSED OF 6 OR MORE TRUSTEES, INCLUDING THE CHAIR, VICE CHAIR, SECRETARY-TREASURER, ONE TRUSTEE SELECTED BY BLOOD CENTERS OF THE PACIFIC, AND TWO OR MORE TRUSTEES SELECTED BY THE BOARD.
FORM 990, PART VI, LINE 11BTHE FORM 990 IS REVIEWED BY MANAGEMENT, INCLUDING CONFIRMATION OF COMPENSATION DISCLOSURES AGAINST W-2 AND 1099 REPORTING. A COPY OF THE DRAFT FORM 990 AND ALL SCHEDULES IS SUPPLIED TO ALL BOARD MEMBERS PRIOR TO THE MEETING HELD TO ACCEPT THE RETURNS. THE W-2S AND 1099S ARE AVAILABLE FOR BOARD REVIEW UPON REQUEST. THE PAID PREPARER, ERNST & YOUNG, AND MEMBERS OF MANAGEMENT REVIEW THE FORM 990 WITH THE COMMITTEES AND ARE AVAILABLE FOR ANSWERING QUESTIONS. ANY COMMENTS FROM THE BOARD ARE CONSIDERED PRIOR TO FILING WITH THE IRS.
FORM 990, PART VI, LINE 12CEACH YEAR, THE BOARD OF TRUSTEES AND SENIOR MANAGEMENT ARE REQUIRED TO SIGN AND RETURN A CONFLICT OF INTEREST FORM TO COMPANY COUNSEL. ANY CONFLICTS DISCLOSED ARE DISCUSSED IN EXECUTIVE SESSION WITH THE BOARD AND RESOLVED. IN ADDITION, IN PREPARATION FOR THE FORM 990 FILING, THE TRUSTEES, OFFICERS AND KEY EMPLOYEES IDENTIFIED ARE REQUIRED TO RESPOND TO A COMPREHENSIVE CONFLICT OF INTEREST AND FAMILY RELATIONSHIP QUESTIONNAIRE. ANY CONFLICTS DISCLOSED ARE DISCUSSED WITH THE BOARD AND DISCLOSED APPROPRIATELY ON THE FORM 990.
FORM 990, PART VI, LINES 15A AND 15BTHE BOARD OF TRUSTEES HAS A COMPENSATION AND HUMAN RESOURCE COMMITTEE WHOSE PURPOSE, AMONG OTHER THINGS, IS TO HIRE AN INDEPENDENT CONSULTING FIRM ONCE EVERY 2-3 YEARS TO PROVIDE DATA ON COMPETITIVENESS OF SALARIES AND BENEFITS FOR THE CEO AND OTHER OFFICERS OF THE CORPORATION. THE MEMBERS OF THE HUMAN RESOURCE AND COMPENSATION COMMITTEE OF THE BOARD ARE ALL INDEPENDENT TRUSTEES AND INCLUDE NO MEMBERS OF MANAGEMENT. THE RECOMMENDATIONS OF THE COMMITTEE ARE REVIEWED BY THE ENTIRE BOARD PRIOR TO APPROVAL. COMPENSATION FOR THESE INDIVIDUALS IS SET AND APPROVED BY THE BOARD EACH YEAR. THE RESULTS OF THESE DISCUSSIONS, REVIEWS AND APPROVALS ARE DOCUMENTED IN THE EXECUTIVE MINUTES OF THE BOARD MEETINGS. THIS PROCESS WAS LAST COMPLETED IN 2015.
FORM 990, PART VI, LINE 19THE FORM 990 IS MADE AVAILABLE ON THE COMPANY'S INTRA-NET FOR ALL OPERATING LOCATIONS TO ACCESS. UPON REQUEST, THE FORM CAN BE PRINTED OR VIEWED ON-LINE. UPON WRITTEN REQUEST TO THE CHIEF FINANCIAL OFFICER, A COPY OF THE FORM 990 WILL BE MAILED TO THE REQUESTOR. THE FORM 990 FOR CURRENT AND PAST YEARS IS ALSO POSTED ON GUIDESTAR FOR ORGANIZATIONS TO ACCESS. THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE NOT MADE AVAILABLE TO THE PUBLIC. THE ORGANIZATION'S COMBINED FINANCIAL STATEMENTS ARE MADE PUBLIC VIA THE ANNUAL REPORT POSTED ON THE ORGANIZATION'S WEBSITE.
FORM 990, PART VIIIN 2012, SALLY CAGLIOTI AND EUGENE ROBERTSON WERE REPORTED AS AN OFFICER AND KEY EMPLOYEE, RESPECTIVELY, OF BLOOD SYSTEMS, INC. ("BSI"). CREATIVE TESTING SOLUTIONS ("CTS"), A RELATED 501(C)(3) ORGANIZATION, LEASED THEIR EMPLOYEES FROM BSI IN 2012, INCLUDING SALLY CAGLIOTI AND EUGENE ROBERTSON. IN 2013 CTS HIRED THEIR OWN EMPLOYEES, INCLUDING SALLY CAGLIOTI AND EUGENE ROBERTSON. THUS, THEY ARE NO LONGER CONSIDERED AN OFFICER OR KEY EMPLOYEE OF BSI. FOR THIS REASON, THEY ARE BEING REPORTED AS FORMER.
FORM 990, PART VIII, LINE 2AAS DESCRIBED IN THE NARRATIVE FOR PART III, LINE 4B, BIOCARE IS A DIVISION OF BLOOD SYSTEMS INC. THE BIOCARE DIVISION WAS CONCEIVED TO PROVIDE BLOOD BANK REAGENTS AND TRANSFUSION MEDICINE-RELATED, PLASMA-DERIVED PHARMACEUTICAL DERIVATIVES TO EXISTING HOSPITAL CUSTOMERS AS A CONVENIENT, VALUE-ADDED SERVICE. CURRENTLY, BIOCARE FUNCTIONS AS A SPECIALTY DISTRIBUTOR OF THERAPEUTIC PLASMA-DERIVATIVE PRODUCTS AND, INCREASINGLY, RECOMBINANT-BASED PRODUCTS TO BLOOD SYSTEMS TRADITIONAL CUSTOMER BASE OF HOSPITALS, AS WELL AS OUT-PATIENT SURGERY CENTERS, SPECIALTY PHARMACIES AND PHYSICIAN PRACTICES. THE MAJORITY OF PRODUCTS SOLD ARE USED TO TREAT DISEASES AND MEDICAL CONDITIONS THAT ARE CONNECTED WITH OR RELATED TO BLOOD OR BLOOD-BORNE MEDICAL CONDITIONS. ALL OF THE PRODUCTS SOLD BY BIOCARE ARE MANUFACTURED BY COMMERCIAL BIO-PHARMACEUTICAL COMPANIES. THE SIGNIFICANT DIFFERENCE BETWEEN BIOCARE AND ITS FOR-PROFIT COMPETITORS IN TERMS OF PRICING IS THAT IN THE EVENT THERE IS A SHORTAGE OF CERTAIN PRODUCT, THE FOR-PROFIT COMPETITORS MAY RAISE THEIR PRICING UP TO TWO OR THREE TIMES NORMAL PRICING, WHILE BIOCARE MAINTAINS ITS PRICING VERY CLOSE TO ORIGINAL LEVELS, ONLY INCREASING PRICING TO OFFSET INCREASED ACQUISITION COSTS. THE REASON BIOCARE HAS TAKEN THIS APPROACH IS DUE TO BSIS EXEMPT PURPOSE TO DELIVER PRODUCTS FOR TRANSFUSION AND TREATMENT PURPOSES. BIOCARE ALSO DIFFERS FROM ITS FOR-PROFIT COMPETITORS IN THAT BIOCARES DISTRIBUTION SERVICES OFFER SAME-DAY AND STAT DELIVERY OPTIONS OVER THE WEEKEND OR AFTER HOURS FOR A MUCH LOWER COST THAN ITS FOR-PROFIT COMPETITORS. BIOCARE REPRESENTS THE FASTEST POSSIBLE OPTION OF GETTING LIFE-SAVING PLASMA-DERIVED AND RECOMBINANT-BASED PRODUCTS TO ITS TRADITIONAL CUSTOMER BASE OVER THE WEEKEND (FRIDAY, SATURDAY AND SUNDAY). MOST FOR-PROFIT COMPETITORS DO PROVIDE 24 HOUR ORDERING SERVICES; HOWEVER, UNLESS AN ORDER IS RECEIVED PRIOR TO THE CLOSE OF BUSINESS ON THURSDAY, THE PRODUCT WILL NOT BE DELIVERED UNTIL THE FOLLOWING WEEK. BIOCARE ALSO USES APPROXIMATELY 20 ORDERING LOCATIONS (FACILITIES) NATIONWIDE THAT ARE CAPABLE OF STORING AND DISTRIBUTING PRODUCT, WHILE MOST COMPETITORS ONLY HAVE A FEW. IT SHOULD BE NOTED THAT THE ACTIVITIES UNDERTAKEN BY BLOOD SYSTEMS RELATED TO ITS EXEMPT PURPOSES AS A WHOLE ARE SUBSTANTIAL AS COMPARED TO THE ACTIVITIES OF THE BIOCARE DIVISION. WHILE BIOCARE COMPRISES A SIGNIFICANT PORTION OF BSIS OVERALL REVENUE, THE NUMBER OF EMPLOYEES (APPROXIMATELY 43) AND HOURS PRODUCING THIS REVENUE IS VERY SMALL, AS COMPARED TO THE TOTAL NUMBER OF BSI EMPLOYEES (APPROXMATELY 2,800) AND HOURS PRODUCING THE RELATED EXEMPT PURPOSE REVENUE. PLASMA-DERIVATIVE PRODUCTS TREATED AS RELATED (COL B) - PLASMA-DERIVATIVE PRODUCTS ARE PRODUCTS THAT ARE MANUFACTURED FROM PROTEINS FOUND IN HUMAN PLASMA AND ARE USED TO TREAT DISEASES AND MEDICAL CONDITIONS THAT ARE CONNECTED WITH OR RELATED TO BLOOD OR BLOOD BORNE MEDICAL CONDITIONS. IT IS BLOOD SYSTEMS POSITION THAT PROVIDING BLOOD-DERIVED PRODUCTS, WHICH ARE MANUFACTURED BY BIO-PHARMACEUTICAL COMPANIES USING HUMAN BLOOD/PLASMA, TO HOSPITALS AND OTHER HEALTHCARE PROVIDERS FOR USE IN TREATING MEDICAL CONDITIONS OF PATIENTS IS DIRECTLY RELATED TO BLOOD SYSTEMS EXEMPT PURPOSES. AS THE PRODUCTS SOLD ARE MADE FROM AND CONTAIN HUMAN BLOOD/PLASMA AND PROTEIN, THERE IS A SUBSTANTIAL NEXUS BETWEEN THE SALE OF THESE PRODUCTS AND BLOOD SYSTEMS EXEMPT PURPOSES. IT SHOULD BE NOTED THAT OTHER NON-PROFIT COMPETITORS ALSO TREAT SIMILAR REVENUE AS RELATED, THUS MAKING IT AN INDUSTRY STANDARD. ACCORDINGLY, THE SALE OF PLASMA-DERIVATIVE PRODUCTS IS BEING TREATED AS RELATED REVENUE (SEE PART VIII, LINE 2A, COLUMN (B)). RECOMBINANT-BASED PRODUCTS TREATED AS UNRELATED (COL C) - RECOMBINANT-BASED PRODUCTS ARE PRODUCTS THAT ARE NOT MADE FROM FRACTIONATED HUMAN PLASMA. INSTEAD, THESE PRODUCTS ARE GENETICALLY ENGINEERED. THE RESULTING PRODUCT HAS THE STRUCTURAL AND FUNCTIONAL CHARACTERISTICS SIMILAR TO THE COMPONENT FOUND IN HUMAN PLASMA (OR BASED ON A PROTEIN IN HUMAN PLASMA) THAT THE DRUG WAS SYNTHESIZED TO IMITATE. IT IS BSIS POSITION THAT THE PROVISION OF RECOMBINANT-BASED DRUG PRODUCTS, WHICH ARE MANUFACTURED THROUGH GENETIC ENGINEERING BY BIO-PHARMACEUTICAL COMPANIES NOT USING HUMAN BLOOD/PLASMA, TO HOSPITALS AND OTHER HEALTHCARE PROVIDERS USED TO TREAT MEDICAL CONDITIONS IS NOT DIRECTLY RELATED TO BLOOD SYSTEMS PURPOSES. ACCORDINGLY, THE SALE OF RECOMBINANT-BASED PRODUCTS IS BEING TREATED AS UNRELATED BUSINESS INCOME (SEE PART VIII, LINE 2A, COLUMN (C)). DUE TO THE GROWTH IN AND EXPANSION OF THE BIOCARE DIVISION, AND THE POSITION RECENTLY TAKEN TO TREAT RECOMBINANT PRODUCTS AS UNRELATED BUSINESS INCOME, BLOOD SYSTEMS INC. FORMED BIOCARE, INC., AN ARIZONA FOR-PROFIT C CORPORATION EFFECTIVE SEPTEMBER 15, 2016. IT IS INTENDED THAT THE BIOCARE DIVISION OF BLOOD SYSTEMS, INC., IN ITS ENTIRETY, WILL BE TRANSFERRED TO AND OPERATED BY BIOCARE, INC. EFFECTIVE JANUARY 1, 2017.
FORM 990, PART XI, LINE 9CTS DISTRIBUTION OF EARNINGS $ 6,500,000 CSIC DISTRIBUTION OF EARNINGS $ 5,000,000 PENSION RECAPTURE EXP OTHER THAN NET PERIODIC COST $(3,294,514) ----------- TOTAL $ 8,205,486

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (9 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdExempt Code SectionExemptCodeSectionTxtPublic Charity StatusPublicCharityStatusTxtBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtControlled OrganizationControlledOrganizationInd
CREATIVE TESTING SOLUTIONS
6210 EAST OAK STREETSCOTTDALEAZ85257271120123SAFETY TEST.AZ501(C)(3)10BSIYes (true)
BLOOD CENTERS OF THE PACIFIC
270 MASONIC AVENUESAN FRANCISCOCA94118941156555BLOOD BANKINGCA501(C)(3)9BSIYes (true)
INLAND NORTHWEST BLOOD CENTER
210 W CATALDO AVENUESPOKANEWA99201910499130BLOOD BANKINGWA501(C)(3)9BSIYes (true)
BLOOD CENTER FND OF THE INLAND NORTHWEST
210 W CATALDO AVENUESPOKANEWA99201464347438FUNDRAISINGWA501(C)(3)7INBCYes (true)
BELLE BONFILS MEMORIAL BLOOD CENTER
717 YOSEMITE STREETDENVERCO80230840411209BLOOD BANKINGCO501(C)(3)9BSIYes (true)
BONFILS BLOOD CENTER FOUNDATION
717 YOSEMITE STREETDENVERCO80230742787586FUNDRAISINGCO501(C)(3)7BBMBCYes (true)
BLOOD BANK OF SAN BERNARDINO & RIVERSIDE
PO BOX 1429SAN BERNARDINOCA92402951708743BLOOD BANKINGCA501(C)(3)9BSIYes (true)
BLOOD BANK SAN BERNARDINORIVERSIDE FDN
PO BOX 1429SAN BERNARDINOCA92402208911074FUNDRAISINGCA501(C)(3)11-TYPE IBBSBRCYes (true)
MID-SOUTH REGIONAL BLOOD CENTER INC
1040 MADISON AVENUEMEMPHISTN38104620719021BLOOD BANKINGTN501(C)(3)9BSIYes (true)

Id Related Org Txbl Partnership IdRelatedOrgTxblPartnershipGrp

Related Organization Name RelatedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1IT SYNERGISTICS LLCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1115 TREE STAddressLine1Txt
CityFLOWOODCityNm
State AbbreviationMSStateAbbreviationCd
ZIP39232ZIPCd
FieldValueIRS element (for citing)
EIN202570319EIN
Primary ActivitiesSOFTWARE DEV.PrimaryActivitiesTxt
Legal Domicile StateMSLegalDomicileStateCd

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1LS & BCRBCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Predominant Income TypeRELATEDPredominantIncomeTypeTxt
Share Of Total Income$0ShareOfTotalIncomeAmt
Share Of EOY Assets$0ShareOfEOYAssetsAmt
Disproportionate AllocationsfalseDisproportionateAllocationsInd
UBI Code V$0UBICodeVAmt
General Or Managing PartnerfalseGeneralOrManagingPartnerInd
Ownership0.00000OwnershipPct

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (2 entries)

Address Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmCountryForeignAddress/CountryCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile Foreign CountryLegalDomicileForeignCountryCdBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtEntity TypeEntityTypeTxtShare Of Total IncomeShareOfTotalIncomeAmtShare Of EOY AssetsShareOfEOYAssetsAmtOwnershipOwnershipPctControlled OrganizationControlledOrganizationIndAddress Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdLegal Domicile StateLegalDomicileStateCd
CANYON STATE INSURANCE COMPANY
WEST BAY ROADGRAND CAYMANCJ981084327INVESTMENTCJBSIFOREIGN$9,045,046$27,629,8251.00000Yes (true)
TRANSFUSION TECHNOLOGY INC
223494865INACTIVEBCRBCC CORP$0$00.00000Yes (true)102 CHESTNUT RIDGE ROADMONTVALENJ07645NJ
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts RyltsYes (true)ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgfalseGiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgYes (true)GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgfalseLoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth OrgfalseLoansOrGuaranteesFromOthOrgInd
Div Related OrganizationYes (true)DivRelatedOrganizationInd
Asset Sale To Other OrgYes (true)AssetSaleToOtherOrgInd
Asset Purchase From Other OrgYes (true)AssetPurchaseFromOtherOrgInd
Asset ExchangefalseAssetExchangeInd
Rental Of Facilities To Oth OrgYes (true)RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth OrgYes (true)RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth OrgYes (true)PerformOfServicesForOthOrgInd
Perform Of Services By Other OrgYes (true)PerformOfServicesByOtherOrgInd
Sharing Of FacilitiesfalseSharingOfFacilitiesInd
Paid Employees SharingfalsePaidEmployeesSharingInd
Reimbursement Paid To Other OrgYes (true)ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgYes (true)ReimbursementPaidByOtherOrgInd
Transfer To Other OrgYes (true)TransferToOtherOrgInd
Transfer From Other OrgYes (true)TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (42 entries)

Transaction TypeTransactionTypeTxtInvolvedInvolvedAmtMethod Of Amount DeterminationMethodOfAmountDeterminationTxt
BLOOD CENTERS OF THE PACIFIC
C$399,326ACCRUAL
BLOOD CENTERS OF THE PACIFIC
G$3,488,226ACCRUAL
BLOOD CENTERS OF THE PACIFIC
H$126,615ACCRUAL
BLOOD CENTERS OF THE PACIFIC
K$1,616,582ACCRUAL
BLOOD CENTERS OF THE PACIFIC
L$3,103,464ACCRUAL
BLOOD CENTERS OF THE PACIFIC
M$186,289ACCRUAL
BLOOD CENTERS OF THE PACIFIC
Q$296,849ACCRUAL
BLOOD CENTERS OF THE PACIFIC
S$293,813ACCRUAL
CANYON STATE INSURANCE COMPANY
F$5,000,000ACCRUAL
CANYON STATE INSURANCE COMPANY
R$534,761ACCRUAL
CREATIVE TESTING SOLUTIONS
M$30,993,748ACCRUAL
CREATIVE TESTING SOLUTIONS
L$5,981,821ACCRUAL
CREATIVE TESTING SOLUTIONS
A$1,108,506ACCRUAL
CREATIVE TESTING SOLUTIONS
J$1,554,338ACCRUAL
CREATIVE TESTING SOLUTIONS
C$1,084,804ACCRUAL
CREATIVE TESTING SOLUTIONS
Q$277,727ACCRUAL
CREATIVE TESTING SOLUTIONS
S$6,500,000ACCRUAL
INLAND NORTHWEST BLOOD CENTER
H$625,953ACCRUAL
INLAND NORTHWEST BLOOD CENTER
L$1,639,318ACCRUAL
INLAND NORTHWEST BLOOD CENTER
Q$92,563ACCRUAL
INLAND NORTHWEST BLOOD CENTER
P$112,500ACCRUAL
INLAND NORTHWEST BLOOD CENTER
C$83,204ACCRUAL
belle BONFILS memorial BLOOD CENTER
G$128,718ACCRUAL
belle BONFILS memorial BLOOD CENTER
H$614,634ACCRUAL
belle BONFILS memorial BLOOD CENTER
L$1,435,429ACCRUAL
belle BONFILS memorial BLOOD CENTER
M$127,599ACCRUAL
belle BONFILS memorial BLOOD CENTER
Q$516,878ACCRUAL
belle BONFILS memorial BLOOD CENTER
C$110,000ACCRUAL
BLOOD BANK OF SAN BERNARDINO & RIVERSIDE
G$12,879,205ACCRUAL
BLOOD BANK OF SAN BERNARDINO & RIVERSIDE
H$751,314ACCRUAL
BLOOD BANK OF SAN BERNARDINO & RIVERSIDE
L$1,231,717ACCRUAL
BLOOD BANK OF SAN BERNARDINO & RIVERSIDE
Q$476,017ACCRUAL
LIFESHARE community blood services
G$1,464,268ACCRUAL
LIFESHARE community blood services
H$116,542ACCRUAL
LIFESHARE community blood services
L$464,350ACCRUAL
LIFESHARE community blood services
Q$131,694ACCRUAL
LIFESHARE community blood services
C$129,472ACCRUAL
BERGEN COMMUNITY REGIONAL BLOOD CENTER
G$871,690ACCRUAL
BERGEN COMMUNITY REGIONAL BLOOD CENTER
L$240,628ACCRUAL
BERGEN COMMUNITY REGIONAL BLOOD CENTER
Q$131,493ACCRUAL
BERGEN COMMUNITY REGIONAL BLOOD CENTER
C$234,504ACCRUAL
Mid-South Regional Blood CenteR INC
Q$105,965ACCRUAL

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.